Abstract

Feeding a modified fish diet has been suggested to improve insulin sensitivity in bottlenose dolphins; however, insulin sensitivity was not directly measured. Since demonstrating an improvement in insulin sensitivity is technically difficult in dolphins, we postulated that directional changes in the hormone axis: fibroblast growth factor 21 (FGF21)/Adiponectin/Ceramide (Cer), could provide further support to this hypothesis. We measured 2-h post-prandial serum FGF21, total adiponectin, percent unmodified adiponectin, ceramide, and sphingosine levels from dolphins fed a diet rich in heptadecanoic acid (C17:0) over 24 weeks. Serum FGF21 was quantified by ELISA with an observed range of 129–1599 pg/ml, but did not significantly change over the 24-week study period. Total adiponectin levels (mean ± SD) significantly increased from 776 ± 400 pmol/ml at week 0 to 1196 ± 467 pmol/ml at week 24. The percent unmodified adiponectin levels (mean ± SD) decreased from 23.8 ± 6.0% at week 0 to 15.2 ± 5.2% at week 24. Interestingly, although FGF21 levels did not change, there was a good correlation between FGF21 and total adiponectin (ρ = 0.788, P < 0.001). We quantified the abundances of serum ceramides and sphingosines (SPH) because adiponectin has a defined role in sphingolipid metabolism through adiponectin receptor-mediated activation of ceramidases. The most abundant ceramide in dolphin sera was Cer 24:1 comprising 49% of the ceramides measured. Significant reductions were observed in the unsaturated Cer 18:1, Cer 20:1, and Cer 24:1, whereas significant increases were observed in saturated Cer 22:0, Cer 24:0, and Cer 26:0. However, total serum ceramides did not change. Significant elevations were detected for total sphingosine, dihydrosphingosine, sphingosine-1-phosphate, and dihydrosphingosine-1-phosphate. Proteomic analysis of the serum proteins revealed few changes in serum proteins over the study period. In conclusion, shifting the dolphin diet to fishes rich in odd chain saturated fatty acids, such as C17:0, resulted in increased serum levels of the insulin sensitizing hormone adiponectin and serum SPH consistent with an insulin-sensitizing phenotype. It is still unclear whether FGF21 plays a role in the regulation of adiponectin in dolphins, similar to that shown in laboratory animal models.

Highlights

  • Dolphins can develop a condition similar to humans with metabolic syndrome that includes elevated serum insulin, glucose, triglycerides, cholesterol, iron, saturated transferrin, ferritin, and total iron, with associated steatosis and iron overload [1,2,3]

  • Because of the challenges in determining insulin resistance in dolphins, we decided to investigate hormonal changes in the insulin sensitizing fibroblast growth factor 21 (FGF21)/adiponectin/ceramide axis that would be consistent with improving insulin sensitivity [5]

  • The insulin sensitizing hormone adiponectin increased in dolphins fed a modified diet over the 24-week period, which supports the hypothesis of increasing insulin sensitivity in dolphins fed a diet higher in mullet or pinfish [3]

Read more

Summary

Introduction

Dolphins can develop a condition similar to humans with metabolic syndrome that includes elevated serum insulin, glucose, triglycerides, cholesterol, iron, saturated transferrin, ferritin, and total iron, with associated steatosis and iron overload [1,2,3]. A study investigating differences in serum lipid profiles between two groups of dolphins, with high or low insulin, found differences in phospholipid fatty acids that may play a role in the susceptibility to or development of an insulin-resistant-like state [3]. A marked reduction in post-prandial variability was noted for serum insulin, triglycerides, and glucose concentrations [3]. This “correction” was interpreted as a possible increase in insulin sensitivity. We postulated that directional changes in other hormone systems, known to improve insulin sensitivity, should change in a direction that supports the hypothesis of improving insulin sensitivity in this small pilot cohort

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.